Correlation Between BridgeBio Pharma and Coya Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BridgeBio Pharma and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BridgeBio Pharma and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BridgeBio Pharma and Coya Therapeutics, Common, you can compare the effects of market volatilities on BridgeBio Pharma and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BridgeBio Pharma with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of BridgeBio Pharma and Coya Therapeutics,.

Diversification Opportunities for BridgeBio Pharma and Coya Therapeutics,

-0.32
  Correlation Coefficient

Very good diversification

The 3 months correlation between BridgeBio and Coya is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding BridgeBio Pharma and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and BridgeBio Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BridgeBio Pharma are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of BridgeBio Pharma i.e., BridgeBio Pharma and Coya Therapeutics, go up and down completely randomly.

Pair Corralation between BridgeBio Pharma and Coya Therapeutics,

Given the investment horizon of 90 days BridgeBio Pharma is expected to generate 1.21 times more return on investment than Coya Therapeutics,. However, BridgeBio Pharma is 1.21 times more volatile than Coya Therapeutics, Common. It trades about 0.07 of its potential returns per unit of risk. Coya Therapeutics, Common is currently generating about 0.03 per unit of risk. If you would invest  868.00  in BridgeBio Pharma on September 6, 2024 and sell it today you would earn a total of  1,842  from holding BridgeBio Pharma or generate 212.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BridgeBio Pharma  vs.  Coya Therapeutics, Common

 Performance 
       Timeline  
BridgeBio Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BridgeBio Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Coya Therapeutics, Common 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Coya Therapeutics, Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Coya Therapeutics, sustained solid returns over the last few months and may actually be approaching a breakup point.

BridgeBio Pharma and Coya Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BridgeBio Pharma and Coya Therapeutics,

The main advantage of trading using opposite BridgeBio Pharma and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BridgeBio Pharma position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.
The idea behind BridgeBio Pharma and Coya Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk